Navigation Links
Drug Improves Mobility in Some MS Patients
Date:2/27/2009

Fampridine may boost walking ability, but some risks tied to dose strength, study says

FRIDAY, Feb. 27 (HealthDay News) -- The drug fampridine improves walking ability in some people with multiple sclerosis.

In a phase III study that included 301 patients, aged 18 to 70, the participants were randomly assigned to receive either 10 milligrams of fampridine or a placebo twice a day for 14 weeks. The patients' walking speed was assessed after two weeks, six weeks, 10 weeks and 14 weeks.

The number of timed walk responders -- those who achieved a faster walking speed in at least three of the four assessments while on treatment compared to when they weren't on treatment -- was 78 out of 224 (35 percent) in the fampridine group and six out of 72 (8 percent) in the placebo group. The patients in the fampridine group also showed greater improvement in leg strength.

Eleven patients (5 percent) in the fampridine group had to withdraw from the study due to adverse events, but only two serious adverse events (focal seizure and severe anxiety) were considered to be connected with the drug, according to Andrew Goodman, of the University of Rochester Medical Center, and colleagues. But they added that the risk of seizure noted in previous studies seems to increase in a dose-dependent way with fampridine.

"Treatment with fampridine produces clinically meaningful improvement in walking ability in some people with multiple sclerosis, irrespective of disease course type or concomitant treatment with immunomodulators," the researchers concluded.

The study was published in this week's edition of The Lancet.

MS patients suffer a progressive decline in mobility, but there are few treatment options available to complement physiotherapy. While it has been suggested that fampridine may improve visual function, strength, walking ability, fatigue and endurance in MS patients, there are questions about the drug's efficacy and safety.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about multiple sclerosis.



-- Robert Preidt



SOURCE: The Lancet, news release, Feb. 27, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
2. Exercise and yoga improves quality of life in women with early-stage breast cancer
3. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
4. Weight-based dosing of ribavirin improves outcomes for patients with hepatitis C
5. Kerry Extends, Improves Small Business Innovation Program
6. Thalidomide Improves Outcomes for Older Myeloma Patients
7. Grape Consumption Improves Antioxidant Capacity in Humans
8. JCSM: CPAP therapy improves symptoms of depression in OSA patients
9. Early intervention dramatically improves outcomes for new dialysis patients
10. New technique improves purity of medicines
11. Novel medication improves ovarian cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Improves Mobility in Some MS Patients
(Date:1/19/2017)... ... January 19, 2017 , ... ... offering treatments for patients with sleep apnea and TMJ disorders. These conditions are ... physical health. Dr. Rassouli provides personalized care to reduce the risk of these ...
(Date:1/19/2017)... ... ... Allegheny Health Network (AHN) officials today announced a bold new step to greatly ... in the greater Pittsburgh region. Starting January 23, patients who call AHN by 11 ... afternoon. , AHN is the first healthcare provider in the region ...
(Date:1/19/2017)... VA (PRWEB) , ... January 19, 2017 , ... Tribble ... services to the eastern Virginia region, is inaugurating a charity event to honor Chad ... , While on duty last year, Chad Phillip Dermyer and his fellow officers were ...
(Date:1/19/2017)... Antonio, TX (PRWEB) , ... January 19, 2017 , ... ... has for the fifth consecutive year donated money to the Triumph Over Kid Cancer ... A. Ragan was one of those children. James saw firsthand the effect of the ...
(Date:1/19/2017)... (PRWEB) , ... January 18, 2017 , ... The CHP ... driving during a rain storm by slowing down and increasing the space between themselves ... 40. Los Angeles based car accident attorney Raymond R. Hassanlou notes that, rain or ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Md. , Jan. 19, 2017 The U.S. ... treatment of Chronic Idiopathic Constipation (CIC) in adult patients. ... from chronic gastrointestinal disorders," said Julie Beitz , M.D., ... FDA,s Center for Drug Evaluation and Research. "With the availability ... most appropriate treatment for their condition." ...
(Date:1/19/2017)... YORK , Jan. 19, 2017 This ... the current and future scenario of the global market. ... rising opioid consumption. Severe chronic constipation is a major ... to traditional laxatives. Hence, novel targeted therapy has been ... OIC sufferers, launch of targeted medicines, and growing awareness ...
(Date:1/19/2017)... LONDON , January 19, 2017 Incretin ... Sympathomimetics and Others The global anti-obesity drugs ... the first half of the forecast period and CAGR of 38.7% ... expected to grow at a CAGR of 32.8% from 2016 to ... million in 2021, and $24,063 million in 2027. ...
Breaking Medicine Technology: